Emcure Pharmaceuticals

Emcure Pharmaceuticals

Pune, India· Est.

A major Indian pharmaceutical company developing and commercializing a broad portfolio of branded generics, biosimilars, and novel formulations across multiple therapeutic areas.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

A major Indian pharmaceutical company developing and commercializing a broad portfolio of branded generics, biosimilars, and novel formulations across multiple therapeutic areas.

Women's HealthCardiovascularAnti-infectivesCritical CareGastroenterologyOncology Supportive Care

Technology Platform

Focuses on complex formulation development, including injectables, liposomal systems, and sustained-release technologies, alongside biopharmaceutical capabilities for biosimilars and novel platforms like mRNA (via subsidiary Gennova).

Opportunities

Significant growth opportunity lies in penetrating regulated markets (US, EU) with complex generics and biosimilars, and leveraging its mRNA technology platform for new vaccine targets beyond COVID-19.

Risk Factors

Faces intense pricing pressure and competition in the global generics market, regulatory hurdles for biosimilar approvals, and execution risk in scaling novel technology platforms like mRNA.

Competitive Landscape

Competes with large Indian pharma companies (Sun Pharma, Dr. Reddy's, Cipla) in generics and domestic markets, and global players in biosimilars. Differentiation stems from vertical integration, focus on complex products, and early investment in next-gen platforms like mRNA.